PerkinElmer and Jacobi Medical Center Establish Research Collaboration to Develop Molecular Diagnostics Screening Platforms

27-Mar-2006

PerkinElmer, Inc. announced a research collaboration agreement with Jacobi Medical Center, which is currently developing a centralized molecular genetics diagnostic laboratory that will ultimately serve the Health and Hospitals Corporation (HHC) of New York City. The collaboration will focus on the development of a genetic screening platform for neonatal, pre-natal and maternal/adult healthcare.

Through the agreement, PerkinElmer will provide Jacobi Medical Center with innovative bead-based multiplex technologies intended to identify and validate biomarkers for genetic diseases.

Other news from the department science

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures
View topic world

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures